Insurers And Government Are Slow To Cover Expensive CAR-T Cancer Therapy - Two approved therapies, with price tags of hundreds of thousands of dollars, have roiled the insurance approval process, leading to delays and, in some cases, denials of coverage, clinicians and analysts say.

Insurers And Government Are Slow To Cover Expensive CAR-T Cancer Therapy - Two approved therapies, with price tags of hundreds of thousands of dollars, have roiled the insurance approval process, leading to delays and, in some cases, denials of coverage, clinicians and analysts say.: https://ift.tt/2mpbQWf Read more... https://ift.tt/2uHKKxd